Showing 4,461 - 4,480 results of 17,576 for search '(( 50 ((ng decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 5 ng decrease ))', query time: 0.82s Refine Results
  1. 4461
  2. 4462
  3. 4463
  4. 4464
  5. 4465
  6. 4466
  7. 4467
  8. 4468

    CircCDK14 ameliorates interleukin-1β-induced chondrocyte damage by the miR-1183/KLF5 pathway in osteoarthritis by Xiaowei Lai (678018)

    Published 2022
    “…</p> <p>CircCDK14 and KLF5 expression were significantly decreased, while miR-1183 was increased in OA cartilage tissues and IL-1β-treated chondrocytes in comparison with controls. …”
  9. 4469
  10. 4470

    Table_3_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).DOCX by Saeid Safiri (3713035)

    Published 2024
    “…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”
  11. 4471

    Table_2_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).DOCX by Saeid Safiri (3713035)

    Published 2024
    “…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”
  12. 4472

    Table_1_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).DOCX by Saeid Safiri (3713035)

    Published 2024
    “…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”
  13. 4473
  14. 4474

    Image_2_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).JPEG by Saeid Safiri (3713035)

    Published 2024
    “…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”
  15. 4475

    Image_1_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).JPEG by Saeid Safiri (3713035)

    Published 2024
    “…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”
  16. 4476

    DataSheet1_Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disord... by Johannes Matthaei (3534620)

    Published 2021
    “…In a second, independent study sample of 50 patients who underwent amitriptyline therapy of 75 mg twice daily, a significant trend of increasing amitriptyline plasma concentrations with decreasing OCT1 activity was observed (p = 0.018), while nortriptyline plasma concentrations were unaffected by the OCT1 genotype. …”
  17. 4477

    Data_Sheet_1_Association between plasma vitamin B5 and coronary heart disease: Results from a case-control study.docx by Pengfei Sun (773177)

    Published 2022
    “…In the threshold effect analysis, the risk of CHD significantly decreased as the vitamin B5 concentration increased (per 10 ng/ml increment: OR, 0.71; 95% CI, 0.57–0.89) in participants with a plasma vitamin B5 concentration of <40.95 ng/ml; however, an increased plasma vitamin B5 concentration was no longer associated with a decreased risk of CHD (per 10 ng/ml increment: OR, 1.00; 95% CI, 0.87–1.14) in participants with a plasma vitamin B5 concentration of ≥40.95 ng/ml. …”
  18. 4478
  19. 4479

    DataSheet1_Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain.docx by Malene Brohus (840080)

    Published 2023
    “…The impact was most severe at low and intermediate Ca<sup>2+</sup> concentrations (up to 4 µM) resulting in more than a 50-fold reduction in Na<sub>V</sub>1.5 binding affinity, and a smaller 1.5 to 11-fold reduction at high Ca<sup>2+</sup> concentrations (25–400 µM). …”
  20. 4480

    Table_5_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.docx by Yishan Liu (10808097)

    Published 2024
    “…</p>Results<p>Of 6,872 critically ill patients, 3,886 (56.5%) had an elevated myoglobin level (≥150 ng/mL) at admission to ICU, and the in-hospital mortality significantly increased when myoglobin level exceeded 1,000 μg/mL. …”